- InspireMD (NSPR, Financial) will release its first quarter 2025 financial results on May 9, 2025.
- The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results.
- InspireMD specializes in the CGuard™ Prime carotid stent system for treating carotid artery disease and stroke prevention.
InspireMD, Inc. (NSPR), the developer of the CGuard™ Prime carotid stent system, has announced the release of its financial results for the first quarter of 2025, scheduled for May 9, 2025. The company will conduct a conference call and webcast at 8:30 a.m. Eastern Time to present their financial performance and recent achievements to investors and stakeholders.
Those interested in joining the live earnings discussion can access the call through telephone numbers 1-800-579-2543 for domestic participants or 1-785-424-1789 for international callers. Alternatively, the live webcast can be accessed through InspireMD's website. A replay of the webcast will be made available shortly after the call's conclusion and will remain archived on the company's website for future access.
InspireMD aims to set an industry standard with its proprietary MicroNet® technology, delivering superior acute results and ensuring long-term, stroke-free outcomes in the carotid stenting sector. The company's common stock is actively traded on Nasdaq under the ticker symbol NSPR.
